S100A7 and acne: Given that P. acnes causes inflammation in acne and that AMPs such as hBD-2, LL-37, S100A7, and RNase 7 show killing activity against P. acnes and inhibit inflammatory reactions mediated by bacterial products, these molecules are potential candidates for the prevention and treatment of acne vulgaris.